MARKET

LQDA

LQDA

Liquidia Corporation
NASDAQ
56.93
-2.37
-4.00%
After Hours: 56.90 -0.03 -0.05% 19:53 05/15 EDT
OPEN
57.74
PREV CLOSE
59.30
HIGH
58.70
LOW
56.08
VOLUME
2.14M
TURNOVER
--
52 WEEK HIGH
59.75
52 WEEK LOW
11.85
MARKET CAP
5.06B
P/E (TTM)
349.05
1D
5D
1M
3M
1Y
5Y
1D
Analysts Are Bullish on Top Healthcare Stocks: Molecular Partners (MOLN), Enliven Therapeutics (ELVN)
TipRanks · 1d ago
Liquidia CEO Roger Jeffs disposes 75,000 common shares worth $4.29 million
PUBT · 1d ago
Analysts Conflicted on These Healthcare Names: RxSight (RXST), Liquidia Technologies (LQDA) and Krystal Biotech (KRYS)
TipRanks · 3d ago
Liquidia Insider Makes Bold Multi-Million Dollar Move
TipRanks · 3d ago
Liquidia director Stephen M. Bloch disposes of shares worth $15,538,414.27
PUBT · 4d ago
Best Momentum Stocks to Buy for May 13th
NASDAQ · 4d ago
New Strong Buy Stocks for May 13th
NASDAQ · 4d ago
Liquidia CEO Roger Jeffs disposes of 75,000 shares worth $3.45 million
PUBT · 4d ago
More
About LQDA
Liquidia Corporation is a biopharmaceutical company. The Company is focused on the development, manufacture and commercialization of products that address unmet patient needs, with a focus directed towards rare cardiopulmonary diseases, such as pulmonaryarterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The Company operate through its wholly owned operating subsidiaries, Liquidia Technologies, Inc. and Liquidia PAH, LLC. Its proprietary PRINT technology is a particle engineering platform, which enable precise production of uniform drug particles. Its lead product candidate is YUTREPIA for the treatment of PAH and PH-ILD. YUTREPIA is an inhaled dry powder formulation of treprostinil designed with PRINT to improve the therapeutic profile of treprostinil by enhancing deep lung delivery while using a convenient, dry-powder inhaler (DPI) and by achieving higher dose levels than the labeled doses of current inhaled therapies.

Webull offers Liquidia Corp stock information, including NASDAQ: LQDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LQDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading LQDA stock methods without spending real money on the virtual paper trading platform.